Ka. Disshon et De. Dluzen, ESTROGEN AS A NEUROMODULATOR OF MPTP-INDUCED NEUROTOXICITY - EFFECTS UPON STRIATAL DOPAMINE RELEASE, Brain research, 764(1-2), 1997, pp. 9-16
The effects of estrogen upon MPTP-induced neurotoxicity were examined
using in vitro superfusion. In Experiment 1, striatal tissue from ovar
iectomized rats was infused with MPP+ (10 mu M), a combination of MPP and 17 beta-estradiol (300 nM), the same dose of estradiol preceding
MPP+, or no treatment infusion. The effects of these treatments on dop
amine release rates during the infusion periods were determined. Infus
ion of MPP+ resulted in a significant increase in dopamine release as
compared to the control. Estradiol added to the MPP+ infusion signific
antly attenuated this dopamine (DA) release, while estradiol treatment
preceding the MPP+ had no effect. In Experiment 2, three different do
ses of estradiol (0.3, 3, or 300 nM) were infused simultaneously with
the MPP+. Doses of estradiol below 300 nM did not attenuate the DA rel
ease. In Experiment 3, estradiol alone (300 nM) was infused, to determ
ine dopamine release rate effects of the hormone itself. There was no
difference between estradiol treated and non-infused control groups. T
hese results demonstrate that the gonadal steroid hormone estradiol ca
n modulate responses of striatal dopamine neurons to MPP+ by altering
the immediate increase in dopamine release which occurs in response to
this neurotoxin. These modulating effects of estradiol are dose-depen
dent, and represent a direct effect upon striatal neurons, most likely
involving a non-genomic mechanism of action. These results implicate
that hormonal modulation of nigrostriatal dopaminergic neurotoxicity m
ay represent an important variable responsible for the sex differences
which are reported in Parkinson's disease. (C) 1997 Elsevier Science
B.V.